During the past decade, Strecker Cancer Center-Belpre conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 129 clinical trials were completed, i.e. on average, 119.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 55 clinical trials were completed. i.e. 203.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Strecker Cancer Center-Belpre" #1 sponsor was "National Cancer Institute (NCI)" with 84 trials, followed by "SWOG Cancer Research Network" with 78 trials sponsored, "Alliance for Clinical Trials in Oncology" with 67 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "Eastern Cooperative Oncology Group" with 18 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Strecker Cancer Center-Belpre" #1 collaborator was "National Cancer Institute (NCI)" with 214 trials as a collaborator, "NRG Oncology" with 28 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "Canadian Cancer Trials Group" with 7 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Strecker Cancer Center-Belpre" are "Breast Cancer" (33 trials), "Lung Cancer" (15 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (12 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Strecker Cancer Center-Belpre" in a lesser frequency.

Most popular intervention types in "Strecker Cancer Center-Belpre" are "Drug" (222 trials), "Other" (161 trials), "Biological" (104 trials), "Procedure" (57 trials) and "Radiation" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (57 trials), "Questionnaire Administration" (32 trials), "placebo" (28 trials) and "Computed Tomography" (25 trials). Other intervention names were less common.

The vast majority of trials in "Strecker Cancer Center-Belpre" are 227 trials for "All" genders, 66 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Strecker Cancer Center-Belpre". undefined are not yet recruiting, 45 are recruiting, 102 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 134 completed trials in Strecker Cancer Center-Belpre, 3 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Strecker Cancer Center-Belpre, 8 "Phase 1" clinical trials were conducted, 135 "Phase 2" clinical trials and 141 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".